Febuwise 40 Tablet contains Febuxostat 40mg, a medication primarily used to manage hyperuricemia in patients with gout. Febuxostat is a xanthine oxidase inhibitor that works by reducing the production of uric acid in the body, thereby preventing the formation of urate crystals that cause joint inflammation and pain associated with gout. This tablet is typically prescribed for individuals who have not responded well to other uric acid-lowering therapies or who are intolerant to allopurinol. Febuwise 40 helps in maintaining lower serum uric acid levels, reducing the frequency of gout attacks, and preventing complications such as tophi and joint damage. It is important to take this medication exactly as prescribed by a healthcare professional, usually once daily, with or without food. Patients should inform their doctor about any history of liver or kidney disease, cardiovascular conditions, or allergies before starting Febuwise 40. Common side effects may include nausea, joint pain, rash, or liver enzyme abnormalities, and any unusual symptoms should be reported promptly. Regular monitoring of uric acid levels and liver function tests is recommended during treatment to ensure safety and efficacy. Febuwise 40 is not intended for use in acute gout attacks but as a long-term management option.